Background: Growing interest has been recently reported in the potential detrimental role of donor gamma-glutamyl transferase (GGT) peak at the time of organ procurement regarding the risk of poor outcomes after liver transplantation (LT). However, the literature on this topic is scarce and controversial data exist on the mechanisms justifying such a correlation. This study aims to demonstrate the adverse effect of donor GGT in a large European LT cohort regarding 90-day post-transplant graft loss. Methods: This is a retrospective international study investigating 1335 adult patients receiving a first LT from January 2004 to September 2018 in four collaborative European centers. Results: Two different multivariable logistic regression models were constructed to evaluate the risk factors for 90-day post-transplant graft loss, introducing donor GGT as a continuous or dichotomous variable. In both models, donor GGT showed an independent role as a predictor of graft loss. In detail, the log-transformed continuous donor GGT value showed an odds ratio of 1.46 (95% CI = 1.03-2.07; p = 0.03). When the donor GGT peak value was dichotomized using a cut-off of 160 IU/L, the odds ratio was 1.90 (95% CI = 1.20-3.02; p = 0.006). When the graft-loss rates were investigated, significantly higher rates were reported in LT cases with donor GGT ≥160 IU/L. In detail, 90-day graft-loss rates were 23.2% vs. 13.9% in patients with high vs. low donor GGT, respectively (log-rank p = 0.004). Donor GGT was also added to scores conventionally used to predict outcomes (i.e., MELD, D-MELD, DRI, and BAR scores). In all cases, when the score was combined with the donor GGT, an improvement in the model accuracy was observed. Conclusions: Donor GGT could represent a valuable marker for evaluating graft quality at transplantation. Donor GGT should be implemented in scores aimed at predicting post-transplant clinical outcomes. The exact mechanisms correlating GGT and poor LT outcomes should be better clarified and need prospective studies focused on this topic.

The role of donor gamma-glutamyl transferase as a risk factor for early graft function after liver transplantation / Lai, Quirino; Melandro, Fabio; Maria Manzia, Tommaso; Spoletini, Gabriele; Crovetto, Anna; Gallo, Gaetano; Hassan, Redan; Mennini, Gianluca; Angelico, Roberta; Avolio, Alfonso; Berrevoet, Frederik; Abreu de Carvalho, Luís; Agnes, Salvatore; Tisone, Giuseppe; Rossi, Massimo. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 12:14(2023), pp. 1-12. [10.3390/jcm12144744]

The role of donor gamma-glutamyl transferase as a risk factor for early graft function after liver transplantation

Quirino LAI
Primo
;
Fabio Melandro;Gabriele Spoletini;Anna Crovetto;Gaetano Gallo;Redan Hassan;Gianluca MENNINI;Massimo Rossi
2023

Abstract

Background: Growing interest has been recently reported in the potential detrimental role of donor gamma-glutamyl transferase (GGT) peak at the time of organ procurement regarding the risk of poor outcomes after liver transplantation (LT). However, the literature on this topic is scarce and controversial data exist on the mechanisms justifying such a correlation. This study aims to demonstrate the adverse effect of donor GGT in a large European LT cohort regarding 90-day post-transplant graft loss. Methods: This is a retrospective international study investigating 1335 adult patients receiving a first LT from January 2004 to September 2018 in four collaborative European centers. Results: Two different multivariable logistic regression models were constructed to evaluate the risk factors for 90-day post-transplant graft loss, introducing donor GGT as a continuous or dichotomous variable. In both models, donor GGT showed an independent role as a predictor of graft loss. In detail, the log-transformed continuous donor GGT value showed an odds ratio of 1.46 (95% CI = 1.03-2.07; p = 0.03). When the donor GGT peak value was dichotomized using a cut-off of 160 IU/L, the odds ratio was 1.90 (95% CI = 1.20-3.02; p = 0.006). When the graft-loss rates were investigated, significantly higher rates were reported in LT cases with donor GGT ≥160 IU/L. In detail, 90-day graft-loss rates were 23.2% vs. 13.9% in patients with high vs. low donor GGT, respectively (log-rank p = 0.004). Donor GGT was also added to scores conventionally used to predict outcomes (i.e., MELD, D-MELD, DRI, and BAR scores). In all cases, when the score was combined with the donor GGT, an improvement in the model accuracy was observed. Conclusions: Donor GGT could represent a valuable marker for evaluating graft quality at transplantation. Donor GGT should be implemented in scores aimed at predicting post-transplant clinical outcomes. The exact mechanisms correlating GGT and poor LT outcomes should be better clarified and need prospective studies focused on this topic.
2023
donor risk index; expanded-criteria donor; graft loss; liver transplantation
01 Pubblicazione su rivista::01a Articolo in rivista
The role of donor gamma-glutamyl transferase as a risk factor for early graft function after liver transplantation / Lai, Quirino; Melandro, Fabio; Maria Manzia, Tommaso; Spoletini, Gabriele; Crovetto, Anna; Gallo, Gaetano; Hassan, Redan; Mennini, Gianluca; Angelico, Roberta; Avolio, Alfonso; Berrevoet, Frederik; Abreu de Carvalho, Luís; Agnes, Salvatore; Tisone, Giuseppe; Rossi, Massimo. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 12:14(2023), pp. 1-12. [10.3390/jcm12144744]
File allegati a questo prodotto
File Dimensione Formato  
Lai_Role_2023.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 537.24 kB
Formato Adobe PDF
537.24 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1693376
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact